Semi-Annual Consolidated Balance Sheet

KYORIN Pharmaceutical Co., Ltd. - Filing #7735653

Concept As at
2017-06-30
As at
2017-03-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
42,859,000,000 JPY
43,619,000,000 JPY
Securities
4,602,000,000 JPY
5,007,000,000 JPY
Other
5,665,000,000 JPY
4,976,000,000 JPY
Allowance for doubtful accounts
-37,000,000 JPY
-44,000,000 JPY
Current assets
121,898,000,000 JPY
126,267,000,000 JPY
Non-current assets
Property, plant and equipment
22,626,000,000 JPY
22,432,000,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
1,144,000,000 JPY
1,204,000,000 JPY
Investments and other assets
46,203,000,000 JPY
42,763,000,000 JPY
Investments and other assets
Investment securities
44,377,000,000 JPY
40,647,000,000 JPY
Other
1,646,000,000 JPY
1,690,000,000 JPY
Allowance for doubtful accounts
-63,000,000 JPY
-65,000,000 JPY
Non-current assets
69,974,000,000 JPY
66,400,000,000 JPY
Assets
191,873,000,000 JPY
192,668,000,000 JPY
Retirement benefit asset
115,000,000 JPY
109,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
11,161,000,000 JPY
11,157,000,000 JPY
Short-term borrowings
843,000,000 JPY
1,321,000,000 JPY
Income taxes payable
493,000,000 JPY
1,194,000,000 JPY
Other
9,566,000,000 JPY
8,601,000,000 JPY
Current liabilities
23,385,000,000 JPY
25,033,000,000 JPY
Non-current liabilities
Long-term borrowings
3,714,000,000 JPY
3,630,000,000 JPY
Retirement benefit liability
1,588,000,000 JPY
1,676,000,000 JPY
Other
2,212,000,000 JPY
2,407,000,000 JPY
Non-current liabilities
9,991,000,000 JPY
9,797,000,000 JPY
Liabilities
33,376,000,000 JPY
34,831,000,000 JPY
Provision for retirement benefits for directors (and other officers)
JPY
16,000,000 JPY
Provision for bonuses
1,289,000,000 JPY
2,690,000,000 JPY
Net assets
Shareholders' equity
Share capital
700,000,000 JPY
700,000,000 JPY
Capital surplus
4,752,000,000 JPY
4,752,000,000 JPY
Retained earnings
149,855,000,000 JPY
150,301,000,000 JPY
Treasury shares
-3,020,000,000 JPY
-3,168,000,000 JPY
Shareholders' equity
152,287,000,000 JPY
152,585,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
8,495,000,000 JPY
7,645,000,000 JPY
Foreign currency translation adjustment
66,000,000 JPY
115,000,000 JPY
Remeasurements of defined benefit plans
-2,352,000,000 JPY
-2,510,000,000 JPY
Valuation and translation adjustments
6,209,000,000 JPY
5,251,000,000 JPY
Net assets
158,497,000,000 JPY
157,837,000,000 JPY
Liabilities and net assets
191,873,000,000 JPY
192,668,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.